Skip to main content
    F

    Fulgent Genetics Inc (FLGT)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $24.07
    -0.59 (-2.37%)

    Market Cap: $688.98M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Fulgent Genetics Inc (FLGT) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Fulgent Genetics are Myriad Genetics (MYGN), NeoGenomics (NEO) and Castle Biosciences (CSTL). By market cap, Fulgent Genetics ranks 10th of the 13 companies on this page; Illumina (ILMN) is the largest at $31.30B. The median P/E of the 5 companies with a P/E is 37.7x.

    Peer Comparison

    FLGT's ROIC of -12.1% is below the peer median of -4.1%, and its revenue growth of 7.5% is below the median of 9.1%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Fulgent Genetics (FLGT)$688.98MN/A2.0x-27.5%-12.1%7.5%0.00%
    Myriad Genetics Inc (MYGN)$542.92MN/A0.7x-16.1%-29.5%-1.5%0.00%
    NeoGenomics Inc (NEO)$2.07B228.9x2.6x-4.1%-2.5%11.4%0.00%
    Castle Biosciences Inc (CSTL)$1.04BN/A2.7x-6.1%-5.4%23.9%0.00%
    Personalis Inc (PSNL)$1.70BN/A20.9x-147.7%N/A76.6%0.00%
    Veracyte Inc (VCYT)$1.96B13.3x3.3x21.8%8.2%15.1%0.00%
    Opko Health Inc (OPK)$1.25BN/A2.4x-22.6%-6.2%15.9%0.00%
    CareDx Inc (CDNA)$4.09B48.2x6.4x25.9%N/A39.3%0.00%
    GRAIL, LLC (GRAL)$5.21BN/A29.6x-243.8%N/A3.7%0.00%
    QuidelOrtho Corp (QDEL)$736.90M11.9x0.3x-14.2%-2.9%-11.6%0.00%
    Illumina Inc (ILMN)$31.30B37.7x6.6x19.7%19.1%4.2%0.00%
    Exagen Inc (XGN)$105.37MN/A1.3x-25.1%-40.4%6.8%0.00%
    Fulcrum Therapeutics Inc (FULC)$287.96MN/AN/A0.0%N/A-100.0%0.00%
    Peer median$1.48B37.7x2.7x-10.1%-4.1%9.1%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Fulgent Genetics, ranked by how closely their business, size, sector and industry match. The largest group, 10 of the 12, is in Diagnostics & Research; the other 2 span 2 industries.

    CompanyAboutPeers
    Myriad Genetics Inc (MYGN)Diagnostics & Research
    Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized...
    MYGN competitors
    NeoGenomics Inc (NEO)Diagnostics & Research
    NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia.
    NEO competitors
    Castle Biosciences Inc (CSTL)Diagnostics & Research
    Castle Biosciences Inc. is a pioneering diagnostics firm that enhances patient care through advanced gene-expression profiling tests...
    CSTL competitors
    Personalis Inc (PSNL)Diagnostics & Research
    Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
    PSNL competitors
    Veracyte Inc (VCYT)Diagnostics & Research
    Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.
    VCYT competitors
    Opko Health Inc (OPK)Diagnostics & Research
    OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico...
    OPK competitors
    CareDx Inc (CDNA)Diagnostics & Research
    CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally.
    CDNA competitors
    GRAIL, LLC (GRAL)Diagnostics & Research
    GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics...
    GRAL competitors
    QuidelOrtho Corp (QDEL)Medical Devices
    Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health...
    QDEL competitors
    Illumina Inc (ILMN)Diagnostics & Research
    Illumina, Inc. is an American company.
    ILMN competitors
    Exagen Inc (XGN)Diagnostics & Research
    Exagen Inc. develops and markets various test products based on its Cell-Bound Complement Activation Products technology under the AVISE brand name...
    XGN competitors
    Fulcrum Therapeutics Inc (FULC)Biotechnology
    Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products to improve the lives of patients with genetically defined...
    FULC competitors

    Frequently Asked Questions About FLGT

    Who are Fulgent Genetics' main competitors?

    The companies most similar to Fulgent Genetics include Myriad Genetics (MYGN), NeoGenomics (NEO), Castle Biosciences (CSTL), Personalis (PSNL) and Veracyte (VCYT), listed from the closest match.

    Who is Fulgent Genetics' biggest competitor?

    Illumina (ILMN) is the largest of the similar companies at $31.30B; Myriad Genetics (MYGN) is the closest match by business profile, size, sector and industry.

    How does FLGT stock compare with its competitors?

    FLGT's P/S is 2.0x against a peer median of 2.7x; its net margin is -27.5% against a peer median of -10.1%.

    Which of Fulgent Genetics' competitors pays a higher dividend?

    Fulgent Genetics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Fulgent Genetics bigger than its competitors?

    No. Fulgent Genetics is 10th by market cap among the 13 companies on this page; the largest is Illumina (ILMN) at $31.30B.